• Structural racism assessed by census tract variables accounts for nearly all Black-White and Hispanic-White disparity in AML survival.

  • Structural racism is a stronger mediator of survival disparities than molecular features, comorbidities, health care access, and treatment.

Non-Hispanic Black (NHB) and Hispanic patients with acute myeloid leukemia (AML) have higher mortality rates than non-Hispanic White (NHW) patients despite more favorable genetics and younger age. A discrete survival analysis was performed on 822 adult patients with AML from 6 urban cancer centers and revealed inferior survival among NHB (hazard ratio [HR] = 1.59; 95% confidence interval [CI]: 1.15, 2.22) and Hispanic (HR = 1.25; 95% CI: 0.88, 1.79) patients compared with NHW patients. A multilevel analysis of disparities was then conducted to investigate the contribution of neighborhood measures of structural racism on racial/ethnic differences in survival. Census tract disadvantage and affluence scores were individually calculated. Mediation analysis of hazard of leukemia death between groups was examined across 6 composite variables: structural racism (census tract disadvantage, affluence, and segregation), tumor biology (European Leukemia Network risk and secondary leukemia), health care access (insurance and clinical trial enrollment), comorbidities, treatment patterns (induction intensity and transplant utilization), and intensive care unit (ICU) admission during induction chemotherapy. Strikingly, census tract measures accounted for nearly all of the NHB-NHW and Hispanic-NHW disparity in leukemia death. Treatment patterns, including induction intensity and allogeneic transplant, and treatment complications, as assessed by ICU admission during induction chemotherapy, were additional mediators of survival disparities in AML. This is the first study to formally test mediators for observed disparities in AML survival and highlights the need to investigate the mechanisms by which structural racism interacts with known prognostic and treatment factors to influence leukemia outcomes.

1.
Siegel
RL
,
Miller
KD
,
Jemal
A
.
Cancer statistics, 2018
.
CA Cancer J Clin.
2018
;
68
(
1
):
7
-
30
.
2.
Singh
GK
,
Jemal
A
.
Socioeconomic and racial/ethnic disparities in cancer mortality, incidence, and survival in the United States, 1950-2014: over six decades of changing patterns and widening inequalities
.
J Environ Public Health.
2017
;
2017
:
2819372
.
3.
Patel
MI
,
Ma
Y
,
Mitchell
BS
,
Rhoads
KF
.
Understanding disparities in leukemia: a national study
.
Cancer Causes Control.
2012
;
23
(
11
):
1831
-
1837
.
4.
Patel
MI
,
Ma
Y
,
Mitchell
BS
,
Rhoads
KF
.
Age and genetics: how do prognostic factors at diagnosis explain disparities in acute myeloid leukemia?
Am J Clin Oncol.
2015
;
38
(
2
):
159
-
164
.
5.
Borate
UM
,
Mineishi
S
,
Costa
LJ
.
Nonbiological factors affecting survival in younger patients with acute myeloid leukemia
.
Cancer.
2015
;
121
(
21
):
3877
-
3884
.
6.
Master
S
,
Munker
R
,
Shi
Z
,
Mills
G
,
Shi
R
.
Insurance status and other non-biological factors predict outcomes in acute myelogenous leukemia: analysis of data from the National Cancer Database
.
Anticancer Res.
2016
;
36
(
9
):
4915
-
4921
.
7.
Jabo
B
,
Morgan
JW
,
Martinez
ME
,
Ghamsary
M
,
Wieduwilt
MJ
.
Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients
.
PLoS One.
2017
;
12
(
4
):
e0174760
.
8.
Ho
G
,
Jonas
BA
,
Li
Q
,
Brunson
A
,
Wun
T
,
Keegan
THM
.
Early mortality and complications in hospitalized adult Californians with acute myeloid leukaemia
.
Br J Haematol.
2017
;
177
(
5
):
791
-
799
.
9.
Krieger
N
,
Chen
JT
,
Waterman
PD
,
Soobader
MJ
,
Subramanian
SV
,
Carson
R
.
Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project
.
Am J Epidemiol.
2002
;
156
(
5
):
471
-
482
.
10.
Rehkopf
DH
,
Haughton
LT
,
Chen
JT
,
Waterman
PD
,
Subramanian
SV
,
Krieger
N
.
Monitoring socioeconomic disparities in death: comparing individual-level education and area-based socioeconomic measures
.
Am J Public Health.
2006
;
96
(
12
):
2135
-
2138
.
11.
Fang
CY
,
Tseng
M
.
Ethnic density and cancer: a review of the evidence
.
Cancer.
2018
;
124
(
9
):
1877
-
1903
.
12.
Döhner
H
,
Estey
EH
,
Amadori
S
, et al;
European LeukemiaNet
.
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
.
Blood.
2010
;
115
(
3
):
453
-
474
.
13.
Dohner
H
,
Estey
E
,
Grimwade
D
, et al
.
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
.
Blood.
2017
;
129
(
4
):
424
-
447
.
14.
Arber
DA
,
Orazi
A
,
Hasserjian
R
, et al
.
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia [correction published in Blood. 2016;128(3):462-463]
.
Blood.
2016
;
127
(
20
):
2391
-
2405
.
15.
Rauscher
GH
,
Campbell
RT
,
Wiley
EL
,
Hoskins
K
,
Stolley
MR
,
Warnecke
RB
.
Mediation of racial and ethnic disparities in estrogen/progesterone receptor-negative breast cancer by socioeconomic position and reproductive factors
.
Am J Epidemiol.
2016
;
183
(
10
):
884
-
893
.
16.
Fairchild
AJ
,
Cai
C
,
McDaniel
H
,
Shi
D
,
Gottschall
A
,
Masyn
KE
.
Evaluating a method to estimate mediation effects with discrete-time survival outcomes
.
Front Psychol.
2019
;
10
:
740
.
17.
Pratschke
J
,
Haase
T
,
Comber
H
,
Sharp
L
,
de Camargo Cancela
M
,
Johnson
H
.
Mechanisms and mediation in survival analysis: towards an integrated analytical framework
.
BMC Med Res Methodol.
2016
;
16
:
27
.
18.
Ditlevsen
S
,
Christensen
U
,
Lynch
J
,
Damsgaard
MT
,
Keiding
N
.
The mediation proportion: a structural equation approach for estimating the proportion of exposure effect on outcome explained by an intermediate variable
.
Epidemiology.
2005
;
16
(
1
):
114
-
120
.
19.
Karlson
KB
,
Holm
A
.
Decomposing primary and secondary effects: a new decomposition method
.
Res Soc Stratification Mobility.
2011
;
29
(
2
):
221
-
237
.
20.
Bhatnagar
B
,
Kohlschmidt
J
,
Mrozek
K
, et al
.
Poor survival and differential impact of genetic features of black patients with acute myeloid leukemia
.
Cancer Discov.
2020
;
11
(
3
):
626
-
637
.
21.
Byrne
MM
,
Halman
LJ
,
Koniaris
LG
,
Cassileth
PA
,
Rosenblatt
JD
,
Cheung
MC
.
Effects of poverty and race on outcomes in acute myeloid leukemia
.
Am J Clin Oncol.
2011
;
34
(
3
):
297
-
304
.
22.
Hong
S
,
Brazauskas
R
,
Hebert
KM
, et al
.
Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States [correction published in Cancer. 2021;127(17):3267]
.
Cancer.
2020
;
127
(
4
):
609
-
618
.
23.
Krieger
N
,
Waterman
PD
,
Batra
N
,
Murphy
JS
,
Dooley
DP
,
Shah
SN
.
Measures of local segregation for monitoring health inequities by local health departments
.
Am J Public Health.
2017
;
107
(
6
):
903
-
906
..
24.
Landrine
H
,
Corral
I
,
Lee
JGL
,
Efird
JT
,
Hall
MB
,
Bess
JJ
.
Residential segregation and racial cancer disparities: a systematic review
.
J Racial Ethn Health Disparities.
2017
;
4
(
6
):
1195
-
1205
.
25.
Bailey
ZD
,
Feldman
JM
,
Bassett
MT
.
How structural racism works: racist policies as a root cause of U.S. racial health inequities
.
N Engl J Med.
2021
;
384
(
8
):
768
-
773
.
26.
Zeidan
AM
,
Podoltsev
NA
,
Wang
X
, et al
.
Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States
.
Blood Adv.
2020
;
4
(
8
):
1615
-
1623
.
27.
Halpern
AB
,
Culakova
E
,
Walter
RB
,
Lyman
GH
.
Association of risk factors, mortality, and care costs of adults with acute myeloid leukemia with admission to the intensive care unit
.
JAMA Oncol.
2017
;
3
(
3
):
374
-
381
.
28.
Paulson
K
,
Brazauskas
R
,
Khera
N
, et al
.
Inferior access to allogeneic transplant in disadvantaged populations: a center for international blood and marrow transplant research analysis
.
Biol Blood Marrow Transplant.
2019
;
25
(
10
):
2086
-
2090
.
29.
Mock
J
,
Meyer
C
,
Mau
LW
, et al
.
Barriers to access to hematopoietic cell transplantation among patients with acute myeloid leukemia in Virginia
.
Transplant Cell Ther.
2021
;
27
(
10
):
869
.
30.
Purnell
TS
,
Simpson
DC
,
Callender
CO
,
Boulware
LE
.
Dismantling structural racism as a root cause of racial disparities in COVID-19 and transplantation
.
Am J Transplant.
2021
;
21
(
7
):
2327
-
2332
.
31.
Bierenbaum
J
,
Davidoff
AJ
,
Ning
Y
,
Tidwell
ML
,
Gojo
I
,
Baer
MR
.
Racial differences in presentation, referral and treatment patterns and survival in adult patients with acute myeloid leukemia: a single-institution experience
.
Leuk Res.
2012
;
36
(
2
):
140
-
145
.
32.
Sekeres
MA
,
Peterson
B
,
Dodge
RK
, et al;
Cancer and Leukemia Group B
.
Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia
.
Blood.
2004
;
103
(
11
):
4036
-
4042
.
33.
Coombs
CC
,
Zehir
A
,
Devlin
SM
, et al
.
Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes
.
Cell Stem Cell.
2017
;
21
(
3
):
374
-
382.e4
.
34.
Bick
AG
,
Weinstock
JS
,
Nandakumar
SK
, et al;
NHLBI Trans-Omics for Precision Medicine Consortium
.
Inherited causes of clonal haematopoiesis in 97,691 whole genomes [correction published in Nature. 2021;591:E27]
.
Nature.
2020
;
586
(
7831
):
763
-
768
.
35.
Cai
Z
,
Kotzin
JJ
,
Ramdas
B
, et al
.
Inhibition of inflammatory signaling in Tet2 mutant preleukemic cells mitigates stress-induced abnormalities and clonal hematopoiesis
.
Cell Stem Cell.
2018
;
23
(
6
):
833
-
849.e5
.
36.
Kaner
J
,
Desai
P
,
Mencia-Trinchant
N
,
Guzman
ML
,
Roboz
GJ
,
Hassane
DC
.
Clonal hematopoiesis and premalignant diseases
.
Cold Spring Harb Perspect Med.
2020
;
10
(
4
):
a035675
.
37.
Bolton
KL
,
Ptashkin
RN
,
Gao
T
, et al
.
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
.
Nat Genet.
2020
;
52
(
11
):
1219
-
1226
.
38.
Hermes
GL
,
Delgado
B
,
Tretiakova
M
, et al
.
Social isolation dysregulates endocrine and behavioral stress while increasing malignant burden of spontaneous mammary tumors
.
Proc Natl Acad Sci U S A.
2009
;
106
(
52
):
22393
-
223938
.
39.
Knight
JM
,
Rizzo
JD
,
Wang
T
, et al
.
Molecular correlates of socioeconomic status and clinical outcomes following hematopoietic cell transplantation for leukemia
.
JNCI Cancer Spectr.
2019
;
3
(
4
):
pkz073
.
40.
Wild
CP
.
Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology
.
Cancer Epidemiol Biomarkers Prev.
2005
;
14
(
8
):
1847
-
1850
.
41.
Mencia-Trinchant
N
,
MacKay
MJ
,
Chin
C
, et al
.
Clonal hematopoiesis before, during, and after human spaceflight
.
Cell Rep.
2020
;
33
(
10
):
108458
.
42.
Gomez-Arteaga
A
,
Mencia-Trinchant
N
,
Tovar
AM
, et al
.
Molecular landscape of acute myeloid leukemia in Mexico. Cancer epidemiology biomarkers
.
Prevention.
2020
;
29
(
6 suppl 1
):
C061
.
43.
Stock
W
,
Luger
SM
,
Advani
AS
, et al
.
A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403
.
Blood.
2019
;
133
(
14
):
1548
-
1559
.
44.
Castillo
JJ
,
Mulkey
F
,
Geyer
S
, et al
.
Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: a pooled analysis from four CALGB (alliance) clinical trials
.
Am J Hematol.
2016
;
91
(
2
):
199
-
204
.
45.
Medeiros
BC
,
Othus
M
,
Estey
EH
,
Fang
M
,
Appelbaum
FR
.
Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia
.
Haematologica.
2012
;
97
(
9
):
1401
-
1404
.
46.
Xing
CY
,
Doose
M
,
Qin
B
, et al
.
Prediagnostic allostatic load as a predictor of poorly differentiated and larger sized breast cancers among black women in the women's circle of health follow-up study
.
Cancer Epidemiol Biomarkers Prev.
2020
;
29
(
1
):
216
-
224
.
47.
Xing
CY
,
Doose
M
,
Qin
B
, et al
.
Pre-diagnostic allostatic load and health-related quality of life in a cohort of Black breast cancer survivors
.
Breast Cancer Res Treat.
2020
;
184
(
3
):
901
-
914
.
48.
Pallok
K
,
De Maio
F
,
Ansell
DA
.
Structural racism: a 60-year-old black woman with breast cancer
.
N Engl J Med.
2019
;
380
(
16
):
1489
-
1493
.
You do not currently have access to this content.

Sign in via your Institution

Sign In